Cargando…

Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents

PURPOSE: To study the prevalence of sustained intraocular pressure (IOP) elevation associated with intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents. METHODS: Prospective comparative study. Non-glaucomatous patients scheduled to receive intravitreal injection of an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiddee, Weerawat, Montriwet, Mayuree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567346/ https://www.ncbi.nlm.nih.gov/pubmed/26360382 http://dx.doi.org/10.1371/journal.pone.0137833

Ejemplares similares

The effects of selective laser trabeculoplasty and travoprost on circadian intraocular pressure fluctuations: A randomized clinical trial
por: Kiddee, Weerawat, et al.
Publicado: (2017)

Mid-Term Impact of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure
por: Hannappe, Marc-Antoine, et al.
Publicado: (2022)

Non-infectious Intraocular Inflammation Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection
por: Kaya, Mahmut, et al.
Publicado: (2021)

Possibility of Neurological Diseases Associated with Acute Acquired Comitant Esotropia
por: Montriwet, Mayuree
Publicado: (2023)

Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids
por: Ben Ghezala, Inès, et al.
Publicado: (2022)

Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis
por: Zhou, Yandan, et al.
Publicado: (2016)

The Effect of Change in Intraocular Pressure on Choroidal Structure in Glaucomatous Eyes
por: Zhang, Xuemin, et al.
Publicado: (2017)

Intravitreal Anti Vascular Endothelial Growth Factor Agents in The Management of Retinal Diseases: An Audit
por: Fiebai, Bassey, et al.
Publicado: (2017)

Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of coats' disease in children
por: Kaul, Shalini, et al.
Publicado: (2010)

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
por: Ruão, Miguel, et al.
Publicado: (2017)

Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
por: Labardini, Cecilia P., et al.
Publicado: (2018)

Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline
por: Nikkhah, Homayoun, et al.
Publicado: (2018)

Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure
por: Nariani, Ashiyana, et al.
Publicado: (2016)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
por: Chatziralli, Irini, et al.
Publicado: (2021)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
por: Hang, Abraham, et al.
Publicado: (2023)

Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown
por: Sindal, Manavi D, et al.
Publicado: (2021)

Glaucomatous optic disc changes despite normal baseline intraocular pressure in a child
por: Hoffman, Brent B., et al.
Publicado: (2018)

Risk of dialysis in patients receiving intravitreal anti–vascular endothelial growth factor treatment: a population-based cohort study
por: Yang, Shun-Fa, et al.
Publicado: (2022)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
por: Lin, Tzu-Yi, et al.
Publicado: (2023)

Changes in anterior chamber biometry and intraocular pressure after uneventful phacoemulsification in non-glaucomatous eyes
por: Dawood, Yousif Farhan, et al.
Publicado: (2023)

Intraocular Pressure Changes: An Important Determinant of the Biocompatibility of Intravitreous Implants
por: Zou, Ling, et al.
Publicado: (2011)

Development of Collapsing Focal and Segmental Glomerulosclerosis After Receiving Intravitreal Vascular Endothelial Growth Factor Blockade
por: Nobakht, Niloofar, et al.
Publicado: (2019)

Comparison of the corrected intraocular pressure by tonopachy with that of Goldmann applanation tonometry in normal and glaucomatous patients
por: Velis, Girish, et al.
Publicado: (2020)

Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema
por: Itou, Junichi, et al.
Publicado: (2023)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Presumed Pyogenic Granuloma Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy
por: Jung, Jesse J, et al.
Publicado: (2011)

Results of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Inflammatory Choroidal Neovascularization
por: Zina, Sourour, et al.
Publicado: (2021)

Staphylococcus lugdunensis Endophthalmitis Following Intravitreal Anti-vascular Endothelial Growth Factor Injections
por: Ahmed, Umar, et al.
Publicado: (2022)

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
por: Rai, Bhim Bahadur, et al.
Publicado: (2023)

Effect of repeated intravitreal anti-vascular endothelial growth factor drugs on corneal nerves
por: Qi, Yuanyuan, et al.
Publicado: (2023)

Intraocular Pressure Following Intravitreal Injection of Triamcinolone Acetonide
por: Ansari, Ejaz A, et al.
Publicado: (2008)

Immediate effect of intravitreal injection of bevacizumab on intraocular pressure
por: Lemos-Reis, Ricardo, et al.
Publicado: (2014)

Safety of Receiving Anti–Vascular Endothelial Growth Factor Intravitreal Injection in Office-Based vs Operating Room Settings: A Meta-analysis
por: Li, Tong, et al.
Publicado: (2021)

Twenty-four-hour repeatability of diurnal intraocular pressure patterns in glaucomatous and ocular hypertensive individuals
por: Hatanaka, Marcelo, et al.
Publicado: (2011)

Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops
por: Yuasa, Yuki, et al.
Publicado: (2019)

Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study
por: Jiang, Lin, et al.
Publicado: (2023)

Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013)

Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia
por: Al-Rashaed, Saba, et al.
Publicado: (2016)

Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
por: Yoon, Jihyun, et al.
Publicado: (2021)

Intravitreal anti-vascular endothelial growth factor injections to treat post-trabeculectomy Swan syndrome
por: Feu-Basilio, Silvia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_59aa0ook3arb505vovu5ilav8l